Clinical trials recruiting in Eskilstuna, Sweden
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 4Not applicable 4
Conditions recruiting in Eskilstuna, Sweden
Recruiting trials in Eskilstuna, Sweden
- A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
- Behavioral Activation for the Prevention and Treatment of Depression in Older Adults in a Municipal Context
- DESTINY Breast Respond HER2-(Ultra)Low Europe
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Common questions
How many clinical trials are recruiting in Eskilstuna, Sweden?
8 recruiting trials have at least one study site in Eskilstuna, Sweden.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.